Vertaling van "trial on reduction of cardiac " (Nederlands → Frans) :

J. Hypertension 21, 1771-1773 (2003) The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators.
J. Hypertension 21, 1771- 1773 (2003) The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators.

31. Auerbach AD, Goldman L. beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review.
30. Auerbach AD, Goldman L. beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review.

CIBIS-II investigators and cornmittees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II) a randomised trial Lancet 353 : 9-13(1999)
CIBIS-II investigators and committees: The Cardiac Insufficiency Bisoprolol Study II (CIBIS- II) a randomised trial. Lancet 353 : 9-13(1999)

In 1999 zijn in de Lancet de resultaten gepubliceerd van twee grootschalige gerandomiseerde dubbelblinde studies waarin het effect van twee cardioselectieve β-blokkers op de mortaliteit bij patiënten met hartfalen werd onderzocht: de CIBIS-II-studie (Cardiac Insufficiency Bisoprolol Study II) en de MERIT-HF-studie (Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure).
Le Lancet a publié en 1999 les résultats de deux grandes études randomisées en double aveugle: l' étude CIBIS-II (Cardiac Insufficiency Bisoprolol Study II) et l' étude MERIT-HF (Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure) qui traitent de l' effet de deux β-bloquants cardiosélectifs sur la mortalité dans l' insuffisance cardiaque.

72. van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer F, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998; 97(6):562-8.
72. van de Watering LM, Hermans J, Houbiers JG, van den Broek PJ, Bouter H, Boer F, et al. Beneficial effects of leukocyte depletion of transfused blood on

A RANDOMIZED CONTROL TRIAL OF AN EXTENSIVE LIFESTYLE MANAGEMENT INTERVENTION (ELMI) FOLLOWING CARDIAC REHABILITATION: STUDY OBSERVATIONS AND BASELINE DATA.
MANAGEMENT INTERVENTION (ELMI) FOLLOWING CARDIAC REHABILITATION : STUDY OBSERVATIONS AND BASELINE DATA.

Townsend T.R., Reitz B.A., Bilker W.B., Bartlett J.G. Clinical trial of cefamandole, cefazolin, and cefuroxime for antibiotic prophylaxis in cardiac operation.
Townsend T.R., Reitz B.A., Bilker W.B., Bartlett J.G.. Clinical trial of cefamandole, cefazolin, and cefuroxime for antibiotic prophylaxis in cardiac operation.

Enfin, en 2003, un article concernant la stratification du risque sur base de variables cliniques et sur base des techniques de diagnostic ainsi que de lÊimpact des traitements sur la réduction du risque est publiée, avec en conclusion, une proposition dÊalgorithme basé essentiellement sur le Revised Cardiac Risk Index 15 .
Enfin, en 2003, un article concernant la stratification du risque sur base de variables cliniques et sur base des techniques de diagnostic ainsi que de lÊimpact des traitements sur la réduction du risque est publiée, avec en conclusion, une proposition dÊalgorithme basé essentiellement sur le Revised Cardiac Risk Index 14 .

clinical trials with veterinary medicines and medical devices for veterinary use ●● Reduction of the backlogs for veterinary
clinical trials with veterinary medicines and medical devices for veterinary use ●● Reduction of the backlogs for veterinary

‐ The Mirasol Clinical Evaluation Study Group. A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology.
the performance and safety of platelets treated with MIRASOL pathogen reduction technology.